F61 injection
/ Sinopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 02, 2022
Clinical Study of F61 Injection in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Wuhan Institute of Biological Products Co., Ltd
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1